Subtypes of mild cognitive impairment in older postmenopausal women: The women s health initiative memory study

Alzheimer Disease and Associated Disorders

Volumn 24, Issue 3, 2010, Pages 248-255

  Rapp, Stephen R ^a   Legault, Claudine ^b   Henderson, Victor W ^c   Brunner, Robert L ^d   Masaki, Kamal ^e   Jones, Beverly ^a   Absher, John ^a   Thal, Leon ^f  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b Department of Biostatistical Sciences ^*  (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cognition; dementia; hormone therapy; MCI; postmenopausal; WHIMS; women

Indexed keywords

ESTROGEN; GESTAGEN;

ADL DISABILITY; AGED; ALGORITHM; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEMORY; MENOPAUSAL SYNDROME; MILD COGNITIVE IMPAIRMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; ALGORITHMS; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; UNITED STATES;

EID: 77956402094     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181d715d5     Document Type: Article

References (40)

1. Levy R. Aging-associated cognitive decline. Int Psychogeriatrics. 1994;6:63-68.
2. Tuokko H, Frerichs RJ. Cognitive impairment with no dementia (CIND): longitudinal studies, the findings, and the issues. Clin Neuropsychol. 2000;14:504-525.
3. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
4. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
5. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
6. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62:1160-1163.
7. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(suppl 1): 65-69.
8. Lopez OL, Becker JT, Jagust WJ, et al. Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry. 2006;77:159-165.
9. Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol. 2003;60:1394-1399. (Pubitemid 37248800)
10. Negash S, Petersen LE, Geda YE, et al. Effects of ApoE genotype and mild cognitive impairment on implicit learning. Neurobiol Aging. 2007;28:885-893.
11. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397-1403.
12. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004;25:303-310.
13. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198-205.
14. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
15. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
16. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194.
17. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women s Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Controlled Clin Trials. 1998;19: 604-621.
18. The Women s Health Initiative Study Group. Design of the Women s Health Initiative clinical trial and observational study. Controlled Clin Trials. 1998;19:61-109.
19. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318.
20. Tractenberg RE, Patterson M, Weiner MF, et al. Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer s disease patients. J Neuropsychiatry Clin Neurosci. 2000;12:472-479.
21. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651-2662.
22. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women s Health Initiative Memory Study. JAMA. 2004;291:2947-2958.
23. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer s Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609-614.
24. Morris JC, Mohs RC, Rogers H, et al. Consortium to establish a registry for Alzheimer s disease (CERAD) clinical and neuropsychological assessment of Alzheimer s disease. Psychopharmacol Bull. 1988;24:641-652.
25. Tariot PN. CERAD behavior rating scale for dementia. Int Psychogeriatr. 1996;8(suppl 3):317-320.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
27. Tschanz JT, Welsh-Bohmer KA, Skoog I, et al. Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology. 2000;54:1290-1296.
28. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women s Health Initiative Memory Study: a Randomized Controlled Trial. JAMA. 2003;289: 2663-2672.
29. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 2003;61:1179-1184.
30. Jungwirth S, Weissgram S, Zehetmayer S, et al. VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. Int J Geriatr Psychiatry. 2005;20:452-458.
31. Lopez OL, Kuller LH, Fitzpatrick A, et al. Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22:1-12. (Pubitemid 36131968)
32. Manly JJ, Bell-McGinty S, Tang MX, et al. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol. 2005;62: 1739-1746.
33. Knopman DS, Roberts RO, Geda YE, et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol. 2009;66:614-619.
34. Jicha GA, Schmitt FA, Abner E, et al. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging. 2008. In press.
35. Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol. 2003;60:1385-1389.
36. Busse A, Hensel A, Guhne U, et al. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 2006; 67:2176-2185.
37. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448-460.
38. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20(3 suppl 2):S69-S74. (Pubitemid 44265854)
39. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer s disease. Curr Neurol Neurosci Rep. 2004;4:374-380.
40. Roe CM, Xiong C, Miller JP, et al. Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology. 2007;68:223-228